These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 32991684)

  • 1. The Role of T-box Transcription Factor in a Pituitary Adenoma Diagnostic Algorithm.
    McDonald WC; McDonald KN; Helmer JA; Ho B; Wang A; Banerji N
    Arch Pathol Lab Med; 2021 May; 145(5):592-598. PubMed ID: 32991684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroidogenic Factor 1, Pit-1, and Adrenocorticotropic Hormone: A Rational Starting Place for the Immunohistochemical Characterization of Pituitary Adenoma.
    McDonald WC; Banerji N; McDonald KN; Ho B; Macias V; Kajdacsy-Balla A
    Arch Pathol Lab Med; 2017 Jan; 141(1):104-112. PubMed ID: 27227698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Complementary Role of Transcription Factors in the Accurate Diagnosis of Clinically Nonfunctioning Pituitary Adenomas.
    Nishioka H; Inoshita N; Mete O; Asa SL; Hayashi K; Takeshita A; Fukuhara N; Yamaguchi-Okada M; Takeuchi Y; Yamada S
    Endocr Pathol; 2015 Dec; 26(4):349-55. PubMed ID: 26481628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digital analysis of hormonal immunostaining in pituitary adenomas classified according to WHO 2017 criteria and correlation with preoperative laboratory findings.
    Tamanini JVG; Dal Fabbro M; de Freitas LLL; Vassallo J; de Souza Queiroz L; Rogerio F
    Neurosurg Focus; 2020 Jun; 48(6):E12. PubMed ID: 32480373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proposal of a clinically relevant working classification of pituitary neuroendocrine tumors based on pituitary transcription factors.
    Silva-Ortega S; García-Martinez A; Niveiro de Jaime M; Torregrosa ME; Abarca J; Monjas I; Picó Alfonso A; Aranda López I
    Hum Pathol; 2021 Apr; 110():20-30. PubMed ID: 33321163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of proopiomelanocortin and pituitary-restricted transcription factor (TPIT), a new marker of normal and adenomatous human corticotrophs.
    Vallette-Kasic S; Figarella-Branger D; Grino M; Pulichino AM; Dufour H; Grisoli F; Enjalbert A; Drouin J; Brue T
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3050-6. PubMed ID: 12843142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multihormonal pituitary adenoma concomitant with Pit-1 and Tpit lineage cells causing acromegaly associated with subclinical Cushing's disease: a case report.
    Takiguchi T; Koide H; Nagano H; Nakayama A; Fujimoto M; Tamura A; Komai E; Shiga A; Kono T; Higuchi S; Sakuma I; Hashimoto N; Suzuki S; Miyabayashi Y; Ishiwatari N; Horiguchi K; Nakatani Y; Yokote K; Tanaka T
    BMC Endocr Disord; 2017 Sep; 17(1):54. PubMed ID: 28865461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription Factor Immunohistochemistry in the Classification of Pituitary Neuroendocrine Tumor/Adenoma: Proposal in a Limited-Resource Setting.
    Sood R; Chatterjee D; Dutta P; Radotra BD
    Arch Pathol Lab Med; 2024 Feb; 148(2):178-189. PubMed ID: 37074863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Parameters of Silent Corticotroph Adenomas With Positive and Negative Adrenocorticotropic Hormone Immunostaining: A Large Retrospective Single-Center Study of 105 Cases.
    Zhang K; Shou X; Chen H; Qiao N; He W; Chen Z; Shen M; Li S; Zhao Y; Zhang Z; Li Y; Ye H; Wang Y
    Front Endocrinol (Lausanne); 2020; 11():608691. PubMed ID: 33584540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and mutation analysis of Tpit in the canine pituitary gland and corticotroph adenomas.
    Hanson JM; Mol JA; Leegwater PA; Bilodeau S; Drouin J; Meij BP
    Domest Anim Endocrinol; 2008 Apr; 34(3):217-22. PubMed ID: 17544240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular, functional, and histopathological classification of the pituitary neuroendocrine neoplasms.
    Inomoto C; Tahara S; Oyama K; Kimura M; Matsuno A; Teramoto A; Osamura RY
    Brain Tumor Pathol; 2021 Jul; 38(3):183-188. PubMed ID: 34269950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unveiling the identities of null cell tumours: Epigenomics corroborate subtle histological cues in pituitary neuroendocrine tumour/adenoma classification.
    Dottermusch M; Schüller U; Hagel C; Saeger W
    Neuropathol Appl Neurobiol; 2023 Feb; 49(1):e12870. PubMed ID: 36527335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Honeycomb Golgi" in pituitary adenomas: not a marker of gonadotroph adenomas.
    Sano T; Mader R; Asa SL; Qian ZR; Hino A; Yamada S
    Endocr Pathol; 2003; 14(4):363-8. PubMed ID: 14739492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of Pit-1 Immunostaining in Distinguishing Pituitary Adenomas of Primitive Differentiation from Null Cell Adenomas.
    Lee JC; Pekmezci M; Lavezo JL; Vogel H; Katznelson L; Fraenkel M; Harsh G; Dulai M; Perry A; Tihan T
    Endocr Pathol; 2017 Dec; 28(4):287-292. PubMed ID: 28994039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplex immunoassays of peptide hormones extracted from formalin-fixed, paraffin-embedded tissue accurately subclassify pituitary adenomas.
    Strathmann FG; Borlee G; Born DE; Gonzalez-Cuyar LF; Huber BR; Baird GS
    Clin Chem; 2012 Feb; 58(2):366-74. PubMed ID: 22205691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Pit-1 and growth hormone-releasing hormone receptor mRNA in human pituitary adenomas: difference among functioning, silent, and other nonfunctioning adenomas.
    Kobayashi I; Oka H; Naritaka H; Sato Y; Fujii K; Kameya T
    Endocr Pathol; 2002; 13(2):83-98. PubMed ID: 12165656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No mutations in TPIT, a corticotroph-specific gene, in human tumoral pituitary ACTH-secreting cells.
    Bucciarelli LG; Pecori Giraldi F; Cavagnini F
    J Endocrinol Invest; 2005 Dec; 28(11):1015-8. PubMed ID: 16483181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double adenomas of the pituitary: transcription factors Pit-1, T-pit, and SF-1 identify cytogenesis and differentiation.
    Jastania RA; Alsaad KO; Al-Shraim M; Kovacs K; Asa SL
    Endocr Pathol; 2005; 16(3):187-94. PubMed ID: 16299401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delineating the Spectrum of Pituitary Adenoma Based on the WHO 2017 Classification.
    Paramita P; Shilpa R; Nandeesh BN; Yasha TC; Vani S
    Neurol India; 2024 Jan; 72(1):96-101. PubMed ID: 38443009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silent corticogonadotroph adenomas: clinical and cellular characteristics and long-term outcomes.
    Cooper O; Ben-Shlomo A; Bonert V; Bannykh S; Mirocha J; Melmed S
    Horm Cancer; 2010 Apr; 1(2):80-92. PubMed ID: 20717480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.